| Immuno-Virological Efficacy of Combination With Trizivir +Tenofovir in Multiresistant HIV Patients (NCT00356616) | Germans Trias i Pujol Hospital | 2005-09-01 |
| Buprenorphine and Integrated HIV Care (NCT00317460) | Yale University | 2005-09-01 |
| HVTN Protocol 204 - A Phase II Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA016-00-VP, Followed by a Multiclade Recombinant Adenoviral Vector HIV-1 Vaccine Boost, VRCHIVADV014-00-VP, in HIV-1 Uninfected Adult Participants (NCT00125970) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-09-01 |
| Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous Meningitis (NCT00433719) | University of Oxford | 2005-09-01 |
| Vicriviroc, a CCR5 Inhibitor, Added to an Optimized Antiretroviral Therapy for Previously Treated HIV (VICTOR-E2) (Study P04285 (NCT00243568) | Merck Sharp & Dohme LLC | 2005-09-01 |
| Metabolic Effects of Enfuvirtide in Healthy Volunteers (NCT00657761) | Hospital Clinic of Barcelona | 2005-09-01 |
| Aging & HIV/AIDS Neurocognitive Sequelae and Functional Consequences (NCT00675766) | US Department of Veterans Affairs | 2005-09-01 |
| Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults (NCT00118898) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2005-09-01 |
| Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome (NCT00656851) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2005-09-01 |
| Boosted Atazanavir and Truvada Given Once-Daily - BATON Study (NCT00224445) | Gilead Sciences | 2005-09-01 |
| Sequential HIV Therapy in Treatment Resistant HIV-1 Infected Patients (NCT00128908) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2005-09-01 |
| Immune Response to Hepatitis C Virus (NCT00165919) | Emory University | 2005-09-01 |
| Risk Assessment of Long-Haul Truck Drivers (NCT00381992) | Wake Forest University Health Sciences | 2005-09-01 |
| Specialized Cognitive-Behavioral Counseling Intervention to Reduce HIV Transmission Risk Behavior in HIV-Infected Men (NCT00218712) | University of California, San Francisco | 2005-09-01 |
| Integrating Buprenorphine Into HIV Treatment (NCT00241930) | Organization to Achieve Solutions in Substance Abuse (OASIS) | 2005-09-01 |
| Preliminary Study of Safety and Efficacy of Policosanol (NCT00312923) | Rush University Medical Center | 2005-09-01 |
| Family Centered Advanced Care Planning for Adolescents With HIV/AIDS and Their Families (NCT00723476) | Maureen Lyon | 2005-09-01 |
| A Study to Explore the Association Between Blood Pressure, HIV and Antiretroviral Therapy (NCT00131807) | Imperial College London | 2005-09-01 |
| Evaluating Host and Viral Factors Among HIV Infected Former Commercial Blood Donors in Fuyang, Anhui Province, China (NCT00346762) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-09-01 |
| Changes in HIV Viral Load in Patients Undergoing Treatment for Filariasis (NCT00344279) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-08-08 |
| WAND Study - A Study to Evaluate Fuzeon (Enfuvirtide) Administered by a Needle-Free Injection Device in Patients With HIV. (NCT00233883) | Hoffmann-La Roche | 2005-08-01 |
| Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Hepatitis C Mono- and Coinfected Patient (PRIVICOP) (NCT00150904) | UMC Utrecht | 2005-08-01 |
| Study of KP-1461 for the Treatment of HIV Positive Patients Who Have Failed Multiple HAART Regimens (NCT00129194) | Koronis Pharmaceuticals. | 2005-08-01 |
| Immunologic Memory (Supp. of ATN 024) (NCT00142753) | University of North Carolina, Chapel Hill | 2005-08-01 |
| The Quality of Life of Patients With Severe Illnesses (NCT00173329) | National Taiwan University Hospital | 2005-08-01 |
| Evaluation of Many Men, Many Voices, An STD/HIV Prevention Intervention for Black MSM (NCT00137631) | Centers for Disease Control and Prevention | 2005-08-01 |
| Predictors of Drug Hypersensitivity in HIV Infected Subjects (NCT00168220) | The Alfred | 2005-08-01 |
| The Pharmacokinetic Study of Saquinavir New Tablet Formulation in HIV-infected Pregnant Women. (NCT00145561) | Radboud University Medical Center | 2005-08-01 |
| Study Evaluating Vaccine in Adults With HIV (NCT00195312) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-08-01 |
| Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy (HIV-AN) or Postherpetic Neuralgia (PHN) (NCT00233155) | NeurogesX | 2005-08-01 |
| Buprenorphine and Integrated HIV Care Evaluation (NCT00124358) | The New York Academy of Medicine | 2005-08-01 |
| Succinylated Human Serum Albumin (Suc-HSA) for HIV-1 Infection (NCT00128063) | International Antiviral Therapy Evaluation Center | 2005-08-01 |
| AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV (NCT00126880) | Avexa | 2005-07-01 |
| Pharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug Combinations (NCT00697892) | Fran Aweeka | 2005-07-01 |
| A Randomized, Dose-ranging Study of Alferon LDO in Asymptomatic HIV+ Subjects (NCT00215852) | AIM ImmunoTech Inc. | 2005-07-01 |
| Social and Economic Outcomes of HIV/AIDS Care and Treatment in HIV Infected South African Adults (NCT00270764) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-07-01 |
| Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication (NCT00296972) | University Health Network, Toronto | 2005-07-01 |
| A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and Amprenavir (NCT00148785) | Emory University | 2005-07-01 |
| Controlling Acute or Early HIV Infection With Antiretroviral Drugs, Without a Candidate Vaccine.As Reported Previously, the Candidate Vaccie Was Not Provided by the Maufacturer as Promised (NCT00238459) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-07-01 |
| Safety and Feasibility Study of Dapivirine (TMC120) Vaginal Ring in Belgium (NCT00332995) | International Partnership for Microbicides, Inc. | 2005-07-01 |
| Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in HIV Infected Patients (NCT00189904) | Bavarian Nordic | 2005-07-01 |
| Managed Problem Solving to Increase Treatment Adherence in Individuals With HIV (NCT00130273) | University of Pennsylvania | 2005-07-01 |
| Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth (NCT00102960) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-07-01 |
| Safety of and Immune Response to a Modified Vaccinia Ankara (MVA) HIV Vaccine in HIV Uninfected Adults (NCT00376090) | U.S. Army Medical Research and Development Command | 2005-07-01 |
| Diet, Exercise and/or Rosiglitazone for HIV-Associated Insulin Resistance (NCT00264251) | St. Luke's-Roosevelt Hospital Center | 2005-07-01 |
| Impact of Anti-HIV Treatment on Labor Productivity and Costs in South Africa (NCT00270725) | Boston University | 2005-07-01 |
| The CORE Buprenorphine Project - An HIV Primary Care Program Demonstration (NCT00227357) | Ruth M. Rothstein CORE Center | 2005-07-01 |
| Vicriviroc (SCH 417690) Treatment Protocol in Human Immunodeficiency Virus (HIV)-Infected Participants: A Rollover Study for ACTG Protocol A5211 (P04100) (NCT00686829) | Merck Sharp & Dohme LLC | 2005-06-30 |
| Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients (NCT00116636) | Therapeutic Concepts | 2005-06-01 |
| Determining the Prevalence of HIV-Related Neurological Disorders in the Asia Pacific (NCT00168246) | National Institute of Mental Health (NIMH) | 2005-06-01 |
| Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART) (NCT00117429) | Marcus Altfeld, M.D., Ph.D. | 2005-06-01 |
| Cardiovascular Risk Evaluation and Antiretrovirals in HIV (NCT01015092) | King's College London | 2005-06-01 |
| An Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Assessment of Bare Spots (NCT00214812) | Biosyn | 2005-06-01 |
| Kaletra Sex/Gender Pharmacokinetics (PK) Study (NCT00148759) | Emory University | 2005-06-01 |
| TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy) (NCT00107887) | Johns Hopkins University | 2005-06-01 |
| A Phase IV Study of BMS-232632 in HIV+ Patients With Metabolic Syndrome (NCT00312754) | Bristol-Myers Squibb | 2005-06-01 |
| TMC114-C209: A Study of Safety of TMC114 With Low Dose Ritonavir (RTV) and Other Antiretrovirals in Experienced HIV-1 Infected Patients With Limited or no Treatment Options (NCT00115050) | Tibotec Pharmaceuticals, Ireland | 2005-06-01 |
| Safety, Tolerance and Acceptability Trial of the Invisible Condom® in Healthy Women (NCT00136643) | Laval University | 2005-06-01 |
| Mindfulness Meditation Training in HIV (NCT00600561) | University of California, Los Angeles | 2005-06-01 |
| Nevirapine Resistance Study: Nevirapine Resistance Among HIV-Infected Mothers (NCT00164762) | Centers for Disease Control and Prevention | 2005-06-01 |
| Effect of Multiple Micronutrient Supplementation on Growth, Morbidity, and Mortality of HIV Infected Children in Uganda (NCT00122941) | Makerere University | 2005-06-01 |
| Bangkok Tenofovir Study, an HIV Pre-exposure Prophylaxis Trial, Bangkok, Thailand (NCT00119106) | Centers for Disease Control and Prevention | 2005-06-01 |
| Impact of HIV and Its Treatment on Reverse Cholesterol Transport (NCT00168233) | The Alfred | 2005-06-01 |
| TH9507 in Patients With HIV-Associated Lipodystrophy (NCT00123253) | Theratechnologies | 2005-06-01 |
| A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected Patients (NCT00398996) | Centre for the AIDS Programme of Research in South Africa | 2005-06-01 |
| Project Hope: Hospital Visit is an Opportunity for Prevention and Engagement With HIV-positive Crack Users (NCT00447798) | Columbia University | 2005-06-01 |
| Central Nervous System Disease in HIV-infected Children on HAART (NCT00110331) | National Cancer Institute (NCI) | 2005-05-03 |
| Monitoring Highly Active Antiretroviral Therapy in HIV-infected Parents in Thailand (NCT00162682) | Institut de Recherche pour le Developpement | 2005-05-01 |
| Anti-HIV Medications for People Recently Infected With HIV (NCT00106171) | Johns Hopkins Bloomberg School of Public Health | 2005-05-01 |
| Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected People in Wenxi County, Shanxi Province, China (NCT00100594) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-05-01 |
| Trichomonas Vaginalis Recurrence Among HIV+ Women (NCT01018095) | Tulane University Health Sciences Center | 2005-05-01 |
| A Study of an Oral Entry Inhibitor, SP01A, in Treatment-Experienced HIV-Infected Patients (NCT00113412) | Samaritan Pharmaceuticals, Inc | 2005-05-01 |
| Project BEST: Buprenorphine Entry Into Substance Abuse Treatment (NCT02583243) | Yale University | 2005-05-01 |
| IL-7 Receptor Polymorphisms and Immune Recovery With HAART (NCT00168207) | The Alfred | 2005-05-01 |
| Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings (NCT00084136) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2005-05-01 |
| Bisphosphonate Therapy for HIV-Infected Adults With Decreased Bone Mineral Density (NCT00102908) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-05-01 |
| Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy (NCT00109603) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-05-01 |
| Acupuncture for Nausea in HIV (NCT00624793) | NYU Langone Health | 2005-05-01 |
| "Prime-Boost" Vaccine Schedule for Prevention of HIV Infection (NCT00109629) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-04-26 |
| Safety of Interleukin-7 in HIV Infected People Currently Taking Anti-HIV Drugs (NCT00099671) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-04-01 |
| A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes (NCT00076232) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-04-01 |
| Psychiatric Problems in Children and Adolescents Infected With HIV at Birth (NCT00100542) | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 2005-04-01 |
| GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection (NCT00105079) | Hoffmann-La Roche | 2005-04-01 |
| Study to Evaluate Changes in CD4 on Replacing TDF With ABC or DDI+TDF With ABC+3TC (NCT00338390) | Hospital de Granollers | 2005-04-01 |
| Stress-Reducing Interventions in HIV+ Patients: Pilot (NCT00599599) | Kent State University | 2005-04-01 |
| A Study of Enfuvirtide (Fuzeon) in Patients With Advanced Human Immunodeficiency Virus-1 (HIV-1) Infection (NCT02569502) | Hoffmann-La Roche | 2005-04-01 |
| Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infection (NCT00476463) | The HIV Netherlands Australia Thailand Research Collaboration | 2005-04-01 |
| Induction-maintenance of Lopinavir/r in HIV-infected Subjects (NCT00159224) | Fundación Huésped | 2005-04-01 |
| Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy (ANRS125) (NCT00120367) | French National Agency for Research on AIDS and Viral Hepatitis | 2005-04-01 |
| Enhancing Oral Health Care Use by HIV Positive Individuals (NCT00444977) | Lisa Metsch | 2005-04-01 |
| Observational Study of Fat Loss in HIV Infected Adults Taking Nucleoside Reverse Transcriptase Inhibitors (NRTIs) (NCT00119405) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-04-01 |
| Three-Dose Regimen of MRKAd5+6 Trigene (V526) in Healthy Adults (V526-001)(COMPLETED) (NCT00850616) | Merck Sharp & Dohme LLC | 2005-04-01 |
| Pediatric Nevirapine Resistance Study (NCT00117728) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2005-04-01 |
| Safety and Efficacy of an Antibody to CCR5 in Individuals With HIV Who Are Not Currently on Antiretroviral Therapy (NCT00114699) | Human Genome Sciences Inc. | 2005-04-01 |
| Safety of and Immune Response to a Pneumococcal Vaccine (PncCV) in HIV Infected and Uninfected Children (NCT00099658) | CIPRA SA | 2005-04-01 |
| Effectiveness of Nucleoside Supplementation or Switch to Tenofovir in Reversing Fat Loss in HIV Infected Adults (NCT00119379) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-04-01 |
| Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS (NCT00106795) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-03-22 |
| HIV Prevention Intervention for People Living With HIV/AIDS (NCT01061021) | University of Connecticut | 2005-03-01 |
| Development of Resistance Mutations in Pregnant HIV-positive (+) Women Following Perinatal Antiretroviral Therapy in Israel (NCT00197366) | Hadassah Medical Organization | 2005-03-01 |
| Episodic Acyclovir Therapy for Genital Ulcers (NCT00164424) | Centers for Disease Control and Prevention | 2005-03-01 |